Grant: Discovery Grants Program - Individual
University of Toronto
$40,000.00
Chemical proteomics platform for drug target discovery and validation
EF 2015-16
Résumé
There is an urgent need to speed up drug discovery and validation pipelines, both in Canada and worldwide. While progress has been made in terms of screening compound libraries, a major limitation is verification of compound mode-of-action. Often the target(s) of a bioactive compound is not known, or is incorrectly hypothesized. This program aims to address this important challenge, and is relevant to a wide range of basic research and applied/commercial problems. A significant positive impact on Canadian biological sciences and health care is anticipated.
The major long-term objectives of this proposal are to develop accurate, sensitive and widely applicable chemical proteomic methods for characterizing (identifying/quantifying) the physical interactions of small molecules/drugs with their corresponding cellular protein target(s) as a means of discovering and/or confirming drug mechanism-of-action and possible 'off-target' effects.
Our proposal combines state-of-the-art protein purification methods, high precision molecular profiling and screening procedures using high performance liquid chromatography / tandem mass spectrometry, and computational tools in an innovative manner to markedly speed up the identification and validation of drug targets. High-thoughput analysis of dozens to hundreds of compounds in a massively parralel manner is planned. The majority of this work will be performed by graduate students and post-doctoral fellows, resulting in a highly competent trainees at the forefront of the burgeoning chemical proteomics field.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
404842-2012
Name nom
Emili, Andrew
Department département
Banting and Best Dept of Medical Research
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2012
Award amount
40000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
4
Nb partie
5
Application title
Chemical proteomics platform for drug target discovery and validation
Keyword
NSERC
Application summary
There is an urgent need to speed up drug discovery and validation pipelines, both in Canada and worldwide. While progress has been made in terms of screening compound libraries, a major limitation is verification of compound mode-of-action. Often the target(s) of a bioactive compound is not known, or is incorrectly hypothesized. This program aims to address this important challenge, and is relevant to a wide range of basic research and applied/commercial problems. A significant positive impact on Canadian biological sciences and health care is anticipated.
The major long-term objectives of this proposal are to develop accurate, sensitive and widely applicable chemical proteomic methods for characterizing (identifying/quantifying) the physical interactions of small molecules/drugs with their corresponding cellular protein target(s) as a means of discovering and/or confirming drug mechanism-of-action and possible 'off-target' effects.
Our proposal combines state-of-the-art protein purification methods, high precision molecular profiling and screening procedures using high performance liquid chromatography / tandem mass spectrometry, and computational tools in an innovative manner to markedly speed up the identification and validation of drug targets. High-thoughput analysis of dozens to hundreds of compounds in a massively parralel manner is planned. The majority of this work will be performed by graduate students and post-doctoral fellows, resulting in a highly competent trainees at the forefront of the burgeoning chemical proteomics field.